LENSAR, Inc. reported strong financial performance for Q4 and full-year 2024, highlighting an 86% increase in the placement of its ALLY Robotic Cataract Laser Systems, with a total of 31 systems ...

Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good morning and thank you for your participation. At this time, ...

The options are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a stock option agreement covering the grant. LENSAR is a commercial-stage medical ...

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...

ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s ...

Shares of Lensar were on track to close at an all-time high after it said revenue is likely to keep growing in 2025. The stock rose 27%, to $12.05, on Thursday, at one point touching a record high of ...

LENSAR Inc (LNSR) reports a 38% revenue increase in Q4 2024, driven by strong ALLY system placements and expanding market ...

Good morning and welcome to the LENSAR fourth quarter in full year 2024 financial results conference call. Earlier this morning, the company issued a press release providing an overview of its ...

Morningstar brands and products Company Portfolio ...

ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of ...

We placed a total of 31 ALLY Systems in the fourth quarter, a new quarterly high for LENSAR. 20 of the 31 systems were installed in the U.S. which is also a single quarter record for the company.